Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AVNT
AVNT logo

AVNT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
39.290
Open
38.170
VWAP
38.59
Vol
575.14K
Mkt Cap
3.54B
Low
37.920
Amount
22.19M
EV/EBITDA(TTM)
9.57
Total Shares
91.71M
EV
4.88B
EV/OCF(TTM)
16.17
P/S(TTM)
1.06
Avient Corporation provides materials solutions. Its portfolio of offerings includes colorants, advanced composites, functional additives, engineered materials, and Dyneema (its ultra-high-molecular-weight polyethylene). Its end markets include consumer, packaging, defense, healthcare, industrial, transportation, building and construction, telecommunications and energy. Its segments include Color, Additives and Inks, and Specialty Engineered Materials. Color, Additives and Inks segment provides specialized custom color and additive concentrates in solid and liquid form for thermoplastics, dispersions for thermosets, as well as specialty inks. Color and additive solutions include an array of colors, special effects and performance-enhancing and sustainable solutions. Specialty Engineered Materials segment provides specialty polymer materials, services and solutions for designers, assemblers and processors of thermoplastic materials across a variety of markets and end-use applications.
Show More

Events Timeline

(ET)
2026-02-12
06:30:00
Company Sees FY26 Adjusted EBITDA of $555M to $585M
select
2026-02-12
06:30:00
Avient Expects Earnings Growth in 2026
select
2026-02-12
06:30:00
Avient Reports Q4 Revenue of $760.6M
select

News

Globenewswire
3.5
04-14Globenewswire
Advanced Materials Science Drives Industry Transformation
  • Biomaterials Breakthrough: Recombinant spider silk produced by genetically engineered silkworms exhibits strength surpassing steel and elasticity exceeding Kevlar, already applied in medicine, military, and high-performance textiles, driving sustainability and functionality enhancements.
  • Defense Application Innovation: L3Harris Technologies has delivered over 1,000 carbon-fiber bomb casings, reducing collateral damage in urban operations and enhancing operational efficiency, showcasing the immense potential of new materials in the military sector.
  • High-Performance Textiles Progress: Kraig Biocraft Laboratories set a record of producing 1.3 metric tons of spider silk in April 2026, with a goal of reaching 10 metric tons monthly, meeting the luxury apparel market's demand for sustainable materials and transforming the textile industry.
  • Aerospace Materials Innovation: Aspen Aerogels' next-generation aerogels are providing thermal protection for hypersonic vehicles and reusable spacecraft, marking the convergence of aerospace technology and advanced materials, driving technological advancements in the aerospace sector.
Newsfilter
3.5
04-14Newsfilter
Advanced Materials Technology Drives Industry Transformation
  • Biomaterials Breakthrough: Recombinant spider silk produced by genetically engineered silkworms exhibits strength surpassing steel and toughness exceeding Kevlar while being fully biodegradable, driving applications in medicine, military, and high-performance textiles, showcasing sustainable potential.
  • Defense Application Innovation: L3Harris Technologies has delivered over 1,000 carbon-fiber bomb casings, reducing dangerous shrapnel in urban operations and enhancing operational safety, highlighting the critical role of new materials in military applications.
  • High-Performance Textiles Development: Kraig Biocraft Laboratories set a record of producing 1.3 metric tons of spider silk in April 2026, with a goal of reaching 10 metric tons per month to meet the demand for sustainable fabrics from high-end athletic and luxury brands, driving market growth.
  • Aerospace Materials Advancement: Aspen Aerogels' next-generation aerogels are providing superior thermal management solutions for hypersonic vehicles and reusable spacecraft, marking the integration of aerospace technology with advanced materials and propelling future aerospace development.
Globenewswire
5.0
04-08Globenewswire
Telix Pharmaceuticals Appoints New Non-Executive Directors
  • Board Expansion: Telix Pharmaceuticals announces the appointment of Maria Rivas and William Jellison as Non-Executive Directors effective May 11, 2026, aimed at enhancing governance and financial oversight to support the company's strategic development in the global biopharmaceutical sector.
  • Rivas's Background: Maria Rivas brings over 25 years of clinical development and commercialization experience, having served as Chief Medical Officer at Pfizer, where she oversaw the launch of multiple blockbuster medical products, and her expertise is expected to bolster Telix's capabilities in oncology and rare diseases.
  • Jellison's Experience: William Jellison has over 30 years of corporate finance leadership experience, including serving as CFO of Stryker Corporation, where he managed international finance and M&A, and his financial acumen will provide critical strategic support for Telix.
  • Strategic Implications: This board expansion aligns with Telix's evolution into a global commercial-stage biopharmaceutical company, reflecting the company's commitment to enhancing governance structures and increasing market competitiveness, which is expected to drive long-term growth in the biopharmaceutical industry.
Newsfilter
5.0
04-08Newsfilter
Telix Pharmaceuticals Appoints New Non-Executive Directors
  • Board Expansion: Telix Pharmaceuticals announces the appointment of Maria Rivas and William Jellison as Non-Executive Directors effective May 11, 2026, aimed at enhancing governance and financial oversight to support the company's strategic development in the global biopharmaceutical sector.
  • Maria Rivas Background: Rivas brings over 25 years of clinical development and commercialization experience, having served as Chief Medical Officer at Pfizer, overseeing the launch of multiple blockbuster drugs, which will provide critical support for Telix's product development and market strategies.
  • William Jellison Credentials: Jellison has over 30 years of corporate finance experience in large regulated environments, previously serving as CFO of Stryker, managing international finance and M&A, and his financial management expertise will enhance Telix's capital allocation efficiency.
  • Strategic Implications: This board expansion aligns with Telix's evolution as a dual-listed global commercial-stage biopharmaceutical company, reflecting the company's commitment to improving governance structures and market competitiveness, which is expected to drive future business growth.
moomoo
5.0
04-08moomoo
TELIX ENHANCES BOARD WITH NEW DIRECTOR APPOINTMENTS
  • New Director Appointments: Telix has strengthened its board by appointing additional directors to enhance governance and strategic oversight.

  • Focus on Growth: The new appointments are part of Telix's strategy to support its growth initiatives and expand its operational capabilities.

PRnewswire
9.5
04-01PRnewswire
Avient Corporation to Release Q1 2026 Earnings on May 7
  • Earnings Release Schedule: Avient Corporation intends to release its Q1 2026 earnings before the market opens on May 7, 2026, which is expected to provide investors with insights into the latest financial performance and business developments.
  • Webcast Meeting: The company will host a webcast at 8:00 a.m. Eastern Time on the same day, featuring a slide presentation that allows investors to receive real-time information and engage interactively.
  • Participant Registration Requirement: Conference call participants must pre-register to obtain the dial-in number and personal PIN, ensuring smooth proceedings and effective information dissemination during the Q&A session.
  • Information Accessibility: The webcast recording and slide presentation will be available immediately after the conference call and accessible for one year, enhancing investors' understanding and engagement with the company's updates.
Wall Street analysts forecast AVNT stock price to rise
5 Analyst Rating
Wall Street analysts forecast AVNT stock price to rise
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
34.00
Averages
39.80
High
50.00
Current: 0.000
sliders
Low
34.00
Averages
39.80
High
50.00
KeyBanc
Aleksey Yefremov
Overweight -> Sector Weight
downgrade
AI Analysis
2026-03-04
Reason
KeyBanc
Aleksey Yefremov
Price Target
AI Analysis
2026-03-04
downgrade
Overweight -> Sector Weight
Reason
KeyBanc analyst Aleksey Yefremov downgraded Avient to Sector Weight from Overweight without a price target. The firm adjusted ratings in the chemicals space as part of a Iran war "commodities playbook." KeyBanc sees the war as a positive catalyst for U.S. petrochemicals. It sees "upside risks" to commodity margins over the next few quarters as rising crude oil prices lift the global cost curve. It cites rising raw material costs for the downgrade of Avient.
Morgan Stanley
Equal Weight
maintain
$41 -> $52
2026-02-17
Reason
Morgan Stanley
Price Target
$41 -> $52
2026-02-17
maintain
Equal Weight
Reason
Morgan Stanley raised the firm's price target on Avient to $52 from $41 and keeps an Equal Weight rating on the shares following Q4 EPS as the firm rolls forward its valuation basis to 2026. The firm issued a corrected note to revise its price target higher following a note that was originally published on February 13.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for AVNT
Unlock Now

Valuation Metrics

The current forward P/E ratio for Avient Corp (AVNT.N) is 12.29, compared to its 5-year average forward P/E of 15.08. For a more detailed relative valuation and DCF analysis to assess Avient Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
15.08
Current PE
12.29
Overvalued PE
17.53
Undervalued PE
12.62

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
9.78
Current EV/EBITDA
7.61
Overvalued EV/EBITDA
10.89
Undervalued EV/EBITDA
8.68

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.05
Current PS
0.99
Overvalued PS
1.20
Undervalued PS
0.90

Financials

AI Analysis
Annual
Quarterly

Whales Holding AVNT

C
Channing Capital Management, LLC
Holding
AVNT
+5.70%
3M Return
P
Palisade Capital Management, LP
Holding
AVNT
+5.55%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Avient Corp (AVNT) stock price today?

The current price of AVNT is 38.55 USD — it has increased 2.44

What is Avient Corp (AVNT)'s business?

Avient Corporation provides materials solutions. Its portfolio of offerings includes colorants, advanced composites, functional additives, engineered materials, and Dyneema (its ultra-high-molecular-weight polyethylene). Its end markets include consumer, packaging, defense, healthcare, industrial, transportation, building and construction, telecommunications and energy. Its segments include Color, Additives and Inks, and Specialty Engineered Materials. Color, Additives and Inks segment provides specialized custom color and additive concentrates in solid and liquid form for thermoplastics, dispersions for thermosets, as well as specialty inks. Color and additive solutions include an array of colors, special effects and performance-enhancing and sustainable solutions. Specialty Engineered Materials segment provides specialty polymer materials, services and solutions for designers, assemblers and processors of thermoplastic materials across a variety of markets and end-use applications.

What is the price predicton of AVNT Stock?

Wall Street analysts forecast AVNT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVNT is39.80 USD with a low forecast of 34.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Avient Corp (AVNT)'s revenue for the last quarter?

Avient Corp revenue for the last quarter amounts to 760.60M USD, increased 1.89

What is Avient Corp (AVNT)'s earnings per share (EPS) for the last quarter?

Avient Corp. EPS for the last quarter amounts to 0.18 USD, decreased -66.04

How many employees does Avient Corp (AVNT). have?

Avient Corp (AVNT) has 9000 emplpoyees as of April 19 2026.

What is Avient Corp (AVNT) market cap?

Today AVNT has the market capitalization of 3.54B USD.